Typhoid vaccine: WHO prequalifies Typbar-TCV
by Press Release from Outbreak News Today on (#3CAX7)
At the end of December 2017, WHO prequalified the first conjugate vaccine for typhoid, Bharat Biotech's Typbar-TCV(R). Typhoid conjugate vaccines (TCVs) are innovative products that have longer-lasting immunity than older vaccines, require fewer doses, and can be given to young children through routine childhood immunization programs. The fact that the vaccine has been prequalified by ["]
The post Typhoid vaccine: WHO prequalifies Typbar-TCV appeared first on Outbreak News Today.